Key facts
- This page summarizes Brian Corvese's Form 4 filing for AGENUS INC (AGEN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2021, 18:58.
Brian Corvese - 16 Jun 2021 Form 4 Insider Report for AGENUS INC (AGEN)
- Reporting relationship
- Director
- Issuer ticker
- AGEN
- Reported as of
- 16 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2021, 18:58:13 UTC
- Prior SEC filing
- 02 Jul 2021
- Next SEC filing
- 20 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam Krauss, as Attorney-in-Fact for Brian Corvese
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Brian Corvese filed Form 4 for AGENUS INC (AGEN) on 21 Jun 2021.
Change
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGEN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +22,471
- Change %
- +32%
- Price
- Shares after
- 92,085
- Date
- 16 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGEN
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -16,000
- Change %
- -50%
- Price
- Shares after
- 16,000
- Date
- 16 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,000
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On June 16, 2020, Mr. Corvese was granted 22,471 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Corvese was issued the underlying 22,471 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.
Footnote F2
On June 16, 2021, Mr. Corvese was granted 16,000 Restricted Stock Unit as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Corvese's continued service on the Board of Directors through such date.